Infinity Pharmaceuticals Inc.

(INFI) Trade

By |

Profile

Infinity Pharmaceuticals Inc is a biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. It is focused on advancing IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate.

Contact Information

Website: www.infi.com
Email: irpr_info@infi.com
Main Phone: +1 617 453-1000
Address: 784 Memorial Drive
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: Adelene Q. Perkins
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 2.04 $ 0. (0.00%)
Last Price 2.04 Change $ 0. Change % 0.00 Tick N/A
Bid 2.03 Bid Size 400.00 Ask 2.04 Ask Size 400.00
Open 2.03 High 2.08 Low 2.02 Prev Close 2.04
Last Trade Volume 126,546 52 Wk Hi 3.75 52 Wk Low 0.93
Market Cap 114.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 56,069,632.00 EPS (TTM) -0.81 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 15
Number of Buys 0 14
Number of Sells 0 1
Net Activity 0 2387583
Last 10 Buys Shares
Lawrence E. Bloch 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Last 10 Sell Shares
Adelene Q. Perkins 1,000
Michael C. Venuti 1,000
Sujay Kango 1,000
Sujay Kango 1,000
Sujay Kango 1,000
Sujay Kango 1,000
Adelene Q. Perkins 1,000
Vito J. Palombella 1,000
Adelene Q. Perkins 1,000
Adelene Q. Perkins 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 4 5 5 4
Mean Target Price Estimate 4.5 5 5 4.5
Standard Deviation 0.71 0 0 0.71
Date of Most Recent Estimate 05/31/18 03/16/18 03/16/18 06/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 1 1 1
Moderate Buy 0 0 0 0
Hold 2 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2.5 2.5 2.5